Arthritis Research & Therapy

official impact factor 4.36

Email this article to a friend

DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis

Piet LCM van Riel* and Jaap Fransen

Arthritis Research & Therapy 2005, 7:189-190 doi:10.1186/ar1820

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.